Platinum(II) 5-substituted-8-hydroxyquinoline coordination compounds induces mitophagy-mediated apoptosis in A549/DDP cancer cells.

[1]  M. Patra,et al.  Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish. , 2022, Journal of medicinal chemistry.

[2]  Zhuo Tang,et al.  Pt(IV) Prodrug as a Potential Antitumor Agent with APE1 Inhibitory Activity. , 2022, Journal of medicinal chemistry.

[3]  Z. Mao,et al.  Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N6-Methyladenosine Methylation. , 2022, Journal of medicinal chemistry.

[4]  Qi-Pin Qin,et al.  Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells. , 2022, European journal of medicinal chemistry.

[5]  Qi-Pin Qin,et al.  Novel 4-/5-bromo-8-hydroxyquinoline cyclometalated iridium(III) complexes as highly potent anticancer and bioimaging agents , 2022, Inorganic Chemistry Communications.

[6]  Yifan Li,et al.  Dinuclear Organoruthenium Complex for Mitochondria-Targeted Near-Infrared Imaging and Anticancer Therapy to Overcome Platinum Resistance. , 2022, Inorganic chemistry.

[7]  Jinxu Qi,et al.  Mechanism of vitamin B6 benzoyl hydrazone platinum(II) complexes overcomes multidrug resistance in lung cancer. , 2022, European journal of medicinal chemistry.

[8]  Dipayan Sarkar,et al.  Topoisomerase I inhibitors: Challenges, progress and the road ahead. , 2022, European journal of medicinal chemistry.

[9]  Zijian Guo,et al.  DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells. , 2021, Journal of medicinal chemistry.

[10]  J. Zhang,et al.  Platinum(IV) complexes as inhibitors of CD47-SIRPα axis for chemoimmunotherapy of cancer. , 2021, European journal of medicinal chemistry.

[11]  P. Sadler,et al.  Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes , 2021, Journal of the American Chemical Society.

[12]  Wei Gao,et al.  Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate. , 2021, European journal of medicinal chemistry.

[13]  F. Rahman,et al.  Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. , 2021, European journal of medicinal chemistry.

[14]  B. Blom,et al.  Homo and heterobimetallic palladium and platinum complexes bearing μ-diphosphane bridges involved in biological studies. , 2021, European journal of medicinal chemistry.

[15]  C. Janiak,et al.  A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy†. , 2021, European journal of medicinal chemistry.

[16]  A. R. Fernandes,et al.  Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties. , 2021, European journal of medicinal chemistry.

[17]  Qi-Pin Qin,et al.  Strong in vitro and in vivo cytotoxic effects of two platinum(II) complexes with cryptolepine derivatives , 2021, Medicinal Chemistry Research.

[18]  Vijay Luxami,et al.  Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry. , 2021, Bioorganic chemistry.

[19]  G. Zhu,et al.  Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues. , 2020, Inorganic chemistry.

[20]  Ting-Ting Wu,et al.  Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors. , 2020, European journal of medicinal chemistry.

[21]  Yong Ling,et al.  Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy. , 2020, European journal of medicinal chemistry.

[22]  Qi-Pin Qin,et al.  Synthesis, characterization and the anticancer activity of six lanthanides(III) complexes with 5,7-dihalogenated-8-quinolinol and 2,2’-bipyridine derivatives , 2020, Transition Metal Chemistry.

[23]  Zhigang Wang,et al.  A photocaged, water-oxidizing, and nucleolus-targeted Pt(IV) complex with a distinct anticancer mechanism. , 2020, Journal of the American Chemical Society.

[24]  Chunyang Jia,et al.  Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes. , 2020, European journal of medicinal chemistry.

[25]  Deqing Zhang,et al.  Pyridinium-substituted tetraphenylethylenes as new autophagy modulators for cancer therapy and the alkyl chain length effect. , 2020, Angewandte Chemie.

[26]  Qi-Pin Qin,et al.  Cyclometalated Ir(III)-8-oxychinolin complexes acting as red-colored probes for specific mitochondrial imaging and anticancer drugs. , 2020, European journal of medicinal chemistry.

[27]  Qi-Pin Qin,et al.  Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives. , 2019, European journal of medicinal chemistry.

[28]  Qi-Pin Qin,et al.  High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives. , 2019, European journal of medicinal chemistry.

[29]  R. Cao,et al.  Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents. , 2019, European journal of medicinal chemistry.

[30]  C. Frochot,et al.  Synthesis and Anticancer Activity of Gold Porphyrin Linked to Malonate Diamine Platinum Complexes. , 2019, Inorganic chemistry.

[31]  Qi-Pin Qin,et al.  Complexes of lanthanides(iii) with mixed 2,2'-bipyridyl and 5,7-dibromo-8-quinolinoline chelating ligands as a new class of promising anti-cancer agents. , 2019, Metallomics : integrated biometal science.

[32]  Qi-Pin Qin,et al.  In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands. , 2019, European journal of medicinal chemistry.

[33]  Qi-Pin Qin,et al.  High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands. , 2019, European journal of medicinal chemistry.

[34]  S. Gou,et al.  Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase. , 2019, European journal of medicinal chemistry.

[35]  Ting Meng,et al.  Bifunctional Mononuclear Dysprosium Complexes: Single-Ion Magnet Behaviors and Antitumor Activities. , 2019, Inorganic chemistry.

[36]  Qi-Pin Qin,et al.  Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities. , 2019, European journal of medicinal chemistry.

[37]  R. Nixon,et al.  Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo , 2018, Autophagy.

[38]  Qi-Pin Qin,et al.  Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway. , 2018, European journal of medicinal chemistry.

[39]  Qi-Pin Qin,et al.  Synthesis and biological evaluation of substituted 3-(2'-benzimidazolyl)coumarin platinum(II) complexes as new telomerase inhibitors. , 2018, Journal of inorganic biochemistry.

[40]  Daniele Veclani,et al.  Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters. , 2018, Journal of the American Chemical Society.

[41]  Zhong-Ying Ma,et al.  Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo. , 2018, European journal of medicinal chemistry.

[42]  S. Parkin,et al.  Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines. , 2018, European journal of medicinal chemistry.

[43]  You-nian Liu,et al.  Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells. , 2018, European journal of medicinal chemistry.

[44]  S. Montgomery,et al.  Ubiquitination of ABCE1 by NOT4 in Response to Mitochondrial Damage Links Co-translational Quality Control to PINK1-Directed Mitophagy. , 2018, Cell metabolism.

[45]  Zhenfeng Chen,et al.  Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells. , 2018, Journal of medicinal chemistry.

[46]  Chengcheng Zhu,et al.  A Potential Bone-Targeting Hypotoxic Platinum(II) Complex with an Unusual Cytostatic Mechanism toward Osteosarcoma Cells. , 2018, Inorganic chemistry.

[47]  C. Orvain,et al.  Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action. , 2018, Inorganic chemistry.

[48]  Ž. Bugarčić,et al.  Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. , 2017, European journal of medicinal chemistry.

[49]  Bo Yang,et al.  Research progress in modern structure of platinum complexes. , 2017, European journal of medicinal chemistry.

[50]  M. Muqit,et al.  Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization , 2017, Journal of medicinal chemistry.

[51]  M. Yaffe,et al.  Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents. , 2017, Journal of the American Chemical Society.

[52]  J. Seo,et al.  Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications. , 2016, Journal of the American Chemical Society.

[53]  Hai-yu Zhou,et al.  Antitumor activities of biscoumarin and dihydropyran derivatives. , 2016, Bioorganic & medicinal chemistry letters.

[54]  A. Schapira,et al.  PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy , 2016, The Journal of cell biology.

[55]  Zheng Tan,et al.  Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy , 2016, Autophagy.

[56]  S. Lippard,et al.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. , 2016, Chemical reviews.

[57]  E. Polverini,et al.  Quinoline-2-carboxaldehyde thiosemicarbazones and their Cu(II) and Ni(II) complexes as topoisomerase IIa inhibitors. , 2015, Journal of inorganic biochemistry.

[58]  Xiaoyong Wang,et al.  Functionalization of Platinum Complexes for Biomedical Applications. , 2015, Accounts of chemical research.

[59]  Qi-Pin Qin,et al.  Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis. , 2015, European journal of medicinal chemistry.

[60]  Yan Peng,et al.  Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine. , 2015, Journal of medicinal chemistry.

[61]  Qiang Zhao,et al.  Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes. , 2014, Angewandte Chemie.

[62]  B. Howerton,et al.  Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents. , 2014, Journal of medicinal chemistry.

[63]  W. Berger,et al.  A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs. , 2014, Journal of medicinal chemistry.

[64]  Daniel F Tardiff,et al.  Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity , 2014, Proceedings of the National Academy of Sciences.

[65]  Justin J. Wilson,et al.  Synthetic methods for the preparation of platinum anticancer complexes. , 2013, Chemical reviews.

[66]  Y. Lam,et al.  Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands. , 2013, Chemical communications.

[67]  J. Padrón,et al.  Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand. , 2013, Dalton transactions.

[68]  Jun Li,et al.  Synthesis and in vitro photodynamic activity of oligomeric ethylene glycol-quinoline substituted zinc(II) phthalocyanine derivatives. , 2013, Journal of medicinal chemistry.

[69]  M. Tegoni,et al.  Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation. , 2012, Journal of medicinal chemistry.

[70]  M. I. Setyawati,et al.  Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation. , 2012, Journal of medicinal chemistry.

[71]  T. Ozben.  Oxidative stress and apoptosis: impact on cancer therapy. , 2007, Journal of pharmaceutical sciences.

[72]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[73]  Per O. Seglen,et al.  Methods for Monitoring Autophagy from Yeast to Human , 2007, Autophagy.

[74]  S. Lippard,et al.  Visualization of nitric oxide in living cells by a copper-based fluorescent probe , 2006, Nature chemical biology.

[75]  P. Skolnick,et al.  Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs. , 1993, Journal of medicinal chemistry.